Tokyo Tape
Sign in
← Yamashita Health Care Holdings

Quarterly report · Q2

9265.TEDINET S100PWJZ
Period2022-06-01 → 2022-11-30
Filed2023-01-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥27.7bn2022-06-01 → 2022-11-30Cons.Net sales
Revenue¥55.1bn2021-06-01 → 2022-05-31Cons.Net sales (5-year summary)
Revenue¥27.3bn2021-06-01 → 2021-11-30Cons.Net sales
Operating income¥598m2022-06-01 → 2022-11-30Cons.Operating income
Operating income¥663m2021-06-01 → 2021-11-30Cons.Operating income
Ordinary income¥624m2022-06-01 → 2022-11-30Cons.Ordinary income
Ordinary income¥1.0bn2021-06-01 → 2022-05-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥701m2021-06-01 → 2021-11-30Cons.Ordinary income
Profit before tax¥20m2022-06-01 → 2022-11-30Cons.Income before income taxes
Profit before tax¥713m2021-06-01 → 2021-11-30Cons.Income before income taxes
Net income (owners)−¥201m2022-06-01 → 2022-11-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥696m2021-06-01 → 2022-05-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥471m2021-06-01 → 2021-11-30Cons.Profit loss attributable to owners of parent
Net income−¥204m2022-06-01 → 2022-11-30Cons.Profit loss
Net income¥471m2021-06-01 → 2021-11-30Cons.Profit loss
Total assets¥22.9bnat 2022-11-30Cons.Assets
Total assets¥24.1bnat 2022-05-31Cons.Assets
Total assets¥25.1bnat 2021-11-30Cons.Total assets (5-year summary)
Total liabilities¥15.3bnat 2022-11-30Cons.Liabilities
Total liabilities¥16.1bnat 2022-05-31Cons.Liabilities
Net assets / equity¥7.6bnat 2022-11-30Cons.Net assets
Net assets / equity¥8.0bnat 2022-05-31Cons.Net assets
Net assets / equity¥7.9bnat 2021-11-30Cons.Net assets (5-year summary)
Cash and deposits¥1.8bnat 2022-11-30Cons.Cash and deposits
Cash and deposits¥4.0bnat 2022-05-31Cons.Cash and deposits
Cash & equivalents¥1.8bnat 2022-11-30Cons.Cash and cash equivalents
Cash & equivalents¥4.0bnat 2022-05-31Cons.Cash and cash equivalents
Cash & equivalents¥2.4bnat 2021-11-30Cons.Cash and cash equivalents
Cash & equivalents¥3.7bnat 2021-05-31dCons.Cash and cash equivalents
Operating cash flow−¥1.9bn2022-06-01 → 2022-11-30Cons.Net cash provided by used in operating activities
Operating cash flow¥581m2021-06-01 → 2022-05-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow−¥751m2021-06-01 → 2021-11-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥88m2022-06-01 → 2022-11-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥27m2021-06-01 → 2022-05-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥318m2021-06-01 → 2021-11-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥209m2022-06-01 → 2022-11-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥229m2021-06-01 → 2022-05-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥229m2021-06-01 → 2021-11-30Cons.Net cash provided by used in financing activities
EPS (basic)¥-78.982022-06-01 → 2022-11-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-143.682022-09-01 → 2022-11-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥272.672021-06-01 → 2022-05-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥184.812021-06-01 → 2021-11-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥128.292021-09-01 → 2021-11-30dCons.Basic earnings loss per share (5-year summary)
Equity ratio33.2%at 2022-11-30Cons.Equity to asset ratio (5-year summary)
Equity ratio33.1%at 2022-05-31Cons.Equity to asset ratio (5-year summary)
Equity ratio31.3%at 2021-11-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 36
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2022-06-01 → 2022-11-30−¥11m
Reconciling Itemsreconcilingrevenue intersegment2022-06-01 → 2022-11-30−¥11m
Reconciling Itemsreconcilingsegment profit2022-06-01 → 2022-11-30−¥447m
jpcrp040300-q2r_E33393-000Medical Equipment Manufacturing And Salesreportable segmentrevenue2022-06-01 → 2022-11-30¥140m
jpcrp040300-q2r_E33393-000Medical Equipment Manufacturing And Salesreportable segmentrevenue external2022-06-01 → 2022-11-30¥140m
jpcrp040300-q2r_E33393-000Medical Equipment Manufacturing And Salesreportable segmentrevenue intersegment2022-06-01 → 2022-11-30¥0
jpcrp040300-q2r_E33393-000Medical Equipment Manufacturing And Salesreportable segmentsegment profit2022-06-01 → 2022-11-30¥3m
jpcrp040300-q2r_E33393-000Medical Equipment Salesreportable segmentrevenue2022-06-01 → 2022-11-30¥27.5bn
jpcrp040300-q2r_E33393-000Medical Equipment Salesreportable segmentrevenue external2022-06-01 → 2022-11-30¥27.5bn
jpcrp040300-q2r_E33393-000Medical Equipment Salesreportable segmentrevenue intersegment2022-06-01 → 2022-11-30¥11m
jpcrp040300-q2r_E33393-000Medical Equipment Salesreportable segmentsegment profit2022-06-01 → 2022-11-30¥1.0bn
jpcrp040300-q2r_E33393-000Medical Mallreportable segmentrevenue2022-06-01 → 2022-11-30¥33m
jpcrp040300-q2r_E33393-000Medical Mallreportable segmentrevenue external2022-06-01 → 2022-11-30¥33m
jpcrp040300-q2r_E33393-000Medical Mallreportable segmentsegment profit2022-06-01 → 2022-11-30¥0
—segment totalrevenue2022-06-01 → 2022-11-30¥27.7bn
—segment totalrevenue external2022-06-01 → 2022-11-30¥27.7bn
—segment totalrevenue intersegment2022-06-01 → 2022-11-30¥11m
—segment totalsegment profit2022-06-01 → 2022-11-30¥1.0bn
Reconciling Itemsreconcilingrevenue2021-06-01 → 2021-11-30¥0
Reconciling Itemsreconcilingrevenue intersegment2021-06-01 → 2021-11-30¥0
Reconciling Itemsreconcilingsegment profit2021-06-01 → 2021-11-30−¥415m
jpcrp040300-q2r_E33393-000Medical Equipment Manufacturing And Salesreportable segmentrevenue2021-06-01 → 2021-11-30¥136m
jpcrp040300-q2r_E33393-000Medical Equipment Manufacturing And Salesreportable segmentrevenue external2021-06-01 → 2021-11-30¥136m
jpcrp040300-q2r_E33393-000Medical Equipment Manufacturing And Salesreportable segmentrevenue intersegment2021-06-01 → 2021-11-30¥0
jpcrp040300-q2r_E33393-000Medical Equipment Manufacturing And Salesreportable segmentsegment profit2021-06-01 → 2021-11-30¥3m
jpcrp040300-q2r_E33393-000Medical Equipment Salesreportable segmentrevenue2021-06-01 → 2021-11-30¥27.2bn
jpcrp040300-q2r_E33393-000Medical Equipment Salesreportable segmentrevenue external2021-06-01 → 2021-11-30¥27.2bn
jpcrp040300-q2r_E33393-000Medical Equipment Salesreportable segmentrevenue intersegment2021-06-01 → 2021-11-30¥0
jpcrp040300-q2r_E33393-000Medical Equipment Salesreportable segmentsegment profit2021-06-01 → 2021-11-30¥1.1bn
jpcrp040300-q2r_E33393-000Medical Mallreportable segmentrevenue2021-06-01 → 2021-11-30¥34m
jpcrp040300-q2r_E33393-000Medical Mallreportable segmentrevenue external2021-06-01 → 2021-11-30¥34m
jpcrp040300-q2r_E33393-000Medical Mallreportable segmentsegment profit2021-06-01 → 2021-11-30¥0
—segment totalrevenue2021-06-01 → 2021-11-30¥27.3bn
—segment totalrevenue external2021-06-01 → 2021-11-30¥27.3bn
—segment totalrevenue intersegment2021-06-01 → 2021-11-30¥0
—segment totalsegment profit2021-06-01 → 2021-11-30¥1.1bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 487
ItemContextValueUnit
Purchase of short term investment securities inv cfPrior1YTDDuration-300000000JPY
Purchase of short term investment securities inv cfCurrentYTDDuration－JPY
Purchase of property plant and equipment inv cfPrior1YTDDuration-89000000JPY
Purchase of property plant and equipment inv cfCurrentYTDDuration-31000000JPY
Purchase of intangible assets inv cfPrior1YTDDuration-4000000JPY
Purchase of intangible assets inv cfCurrentYTDDuration-31000000JPY
Purchase of investment securities inv cfPrior1YTDDuration-32000000JPY
Purchase of investment securities inv cfCurrentYTDDuration-2000000JPY
Purchase of stocks of subsidiaries and affiliates inv cfPrior1YTDDuration－JPY
Purchase of stocks of subsidiaries and affiliates inv cfCurrentYTDDuration-30000000JPY
Proceeds from purchase of investments in subsidiaries resulting in change in scope of consolidation inv cfPrior1YTDDuration100000000JPY
Proceeds from purchase of investments in subsidiaries resulting in change in scope of consolidation inv cfCurrentYTDDuration－JPY
Net cash provided by used in investment activitiesPrior1YTDDuration-318000000JPY
Net cash provided by used in investment activitiesCurrentYTDDuration-88000000JPY
Cash dividends paid fin cfPrior1YTDDuration-229000000JPY
Cash dividends paid fin cfCurrentYTDDuration-209000000JPY
Net cash provided by used in financing activitiesPrior1YTDDuration-229000000JPY
Net cash provided by used in financing activitiesCurrentYTDDuration-209000000JPY
Net increase decrease in cash and cash equivalentsPrior1YTDDuration-1299000000JPY
Net increase decrease in cash and cash equivalentsCurrentYTDDuration-2162000000JPY
Cash and cash equivalentsPrior2YearInstant3652000000JPY
Cash and cash equivalentsPrior1YearInstant3975000000JPY
Cash and cash equivalentsPrior1QuarterInstant2352000000JPY
Cash and cash equivalentsCurrentQuarterInstant1812000000JPY
Salaries and allowances sgaPrior1YTDDuration1515000000JPY
Salaries and allowances sgaCurrentYTDDuration1579000000JPY
Provision for bonuses sgaPrior1YTDDuration182000000JPY
Provision for bonuses sgaCurrentYTDDuration181000000JPY
Retirement benefit expenses sgaPrior1YTDDuration66000000JPY
Retirement benefit expenses sgaCurrentYTDDuration82000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q2r_E33393-000MedicalEquipmentSalesReportableSegmentsMember27165000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q2r_E33393-000MedicalEquipmentManufacturingAndSalesReportableSegmentMember136000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q2r_E33393-000MedicalMallReportableSegmentsMember34000000JPY
Revenues from external customersPrior1YTDDuration_ReportableSegmentsMember27335000000JPY
Revenues from external customersPrior1YTDDuration_ReconcilingItemsMember－JPY
Revenues from external customersPrior1YTDDuration27335000000JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q2r_E33393-000MedicalEquipmentSalesReportableSegmentsMember0JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q2r_E33393-000MedicalEquipmentManufacturingAndSalesReportableSegmentMember0JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q2r_E33393-000MedicalMallReportableSegmentsMember－JPY
Transactions with other segmentsPrior1YTDDuration_ReportableSegmentsMember0JPY
Transactions with other segmentsPrior1YTDDuration_ReconcilingItemsMember-0JPY
Transactions with other segmentsPrior1YTDDuration－JPY
Net salesPrior1YTDDuration_jpcrp040300-q2r_E33393-000MedicalEquipmentSalesReportableSegmentsMember27165000000JPY
Net salesPrior1YTDDuration_jpcrp040300-q2r_E33393-000MedicalEquipmentManufacturingAndSalesReportableSegmentMember136000000JPY
Net salesPrior1YTDDuration_jpcrp040300-q2r_E33393-000MedicalMallReportableSegmentsMember34000000JPY
Net salesPrior1YTDDuration_ReportableSegmentsMember27336000000JPY
Net salesPrior1YTDDuration_ReconcilingItemsMember-0JPY
Net salesPrior1YTDDuration27335000000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q2r_E33393-000MedicalEquipmentSalesReportableSegmentsMember1073000000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q2r_E33393-000MedicalEquipmentManufacturingAndSalesReportableSegmentMember3000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2022-05-31pass
balance sheet identityconsolidated 2022-11-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-05-31pass
statement vs summary · net assetsconsolidated 2022-11-30pass
statement vs summary · net income attributable to parentconsolidated 2021-06-01/2021-11-30pass
statement vs summary · net income attributable to parentconsolidated 2022-06-01/2022-11-30pass
statement vs summary · operating cash flowconsolidated 2021-06-01/2021-11-30pass
statement vs summary · operating cash flowconsolidated 2022-06-01/2022-11-30pass
statement vs summary · revenueconsolidated 2021-06-01/2021-11-30pass
statement vs summary · revenueconsolidated 2022-06-01/2022-11-30pass
statement vs summary · total assetsconsolidated 2022-05-31pass
statement vs summary · total assetsconsolidated 2022-11-30pass